What they were paid
Vera Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | — | $296,660 | $0 | $356,660 |
| FY2024 | $60,000 | $0 | $386,589 | $0 | $446,589 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vera Therapeutics, Inc. DEF 14A filed April 9, 2026, accession 0001140361-26-014002, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Vera Therapeutics pays directors a $40,000 cash retainer and $400,000 in Options.
Committees
FY2025 · as the proxy prints themAudit (Chair)
The rest of the Vera Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Cheng, M.D., Ph.D | Independent Director | $344,160 |
| Beth Seidenberg, M.D | Independent Director | $346,660 |
| Christopher Hite | Independent Director | — |
| Christy Oliger | Independent Director | $341,660 |
| James R. Meyers | Independent Director | $740,641 |
| Kimball Hall | Independent Director | $344,160 |
| Maha Katabi, Ph.D | Independent Director | $346,660 |
| Marshall Fordyce, M.D | Director | $0 |
| Michael M. Morrissey, Ph.D | Chair of the Board | $386,660 |
| Patrick G. Enright | Independent Director | $351,660 |
The full Vera Therapeutics compensation record
free company briefThis page is one director within Vera Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat